5:40 PM
 | 
Feb 17, 2012
 |  BC Extra  |  Company News

Amsterdam Molecular to transfer assets, delist

Amsterdam Molecular Therapeutics Holding N.V. (Euronext:AMT) said its board unanimously recommended dissolving the company's assets into newly formed uniQure B.V. (Amsterdam, the Netherlands) in a stock deal. Amsterdam said it is facing a "precarious" financial position with cash expected to last until April and the deal is "the only viable way to secure a capital injection."...

Read the full 263 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >